The US Oncology Network
With community oncology ‘at risk’, alliance outlines prescription for health care reform
Debra Patt, MD, PhD, MBA, FASCO, has often found her career has placed her at the intersection of public policy and clinical informatics.
Study reveals ‘multifaceted consequences’ of cisplatin shortage
Findings presented at ASCO Quality Care Symposium provided new insights into the effects last year’s cisplatin shortage had on patients with head and neck cancer.
Regimen confers ‘clinically meaningful’ PFS benefit in relapsed multiple myeloma
CHICAGO — The addition of belantamab mafodotin to pomalidomide and dexamethasone improved outcomes compared with standard care for patients with relapsed or refractory multiple myeloma, according to data presented at ASCO Annual Meeting.
Use of lower-cost drugs reduces cancer care costs while maintaining quality
Lower-cost alternative drugs reduced total costs of care by approximately 5% while maintaining quality care among Medicare beneficiaries with cancer, according to study results presented at ASCO Quality Care Symposium.
VIDEO: Results from SPOTLIGHT study ‘very exciting’
In this video, Mark T. Fleming, MD, discusses results from the SPOTLIGHT study, which he presented at this year’s American Urological Association meeting.
Tesetaxel-capecitabine may provide all-oral option for metastatic breast cancer subset
The addition of tesetaxel to reduced-dose capecitabine improved PFS among women with HER2-negative, hormone receptor-positive metastatic breast cancer, according to study results presented at the virtual San Antonio Breast Cancer Symposium.